← Back to Clinical Trials
Recruiting NCT07239583

Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )

Trial Parameters

Condition Respiratory Syncytial Virus Infection
Sponsor Tam Anh Research Institute
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 60 Years
Max Age N/A
Start Date 2025-10-06
Completion 2026-12-30

Brief Summary

This observational, prospective, multicenter study aims to estimate the proportion of RSV infection in adults aged 60 years and older hospitalized due to acute respiratory infections or exacerbation of cardiopulmonary disease.

Eligibility Criteria

Inclusion Criteria: To be enrolled in the study, participants must meet all inclusion criteria: 1. Individuals ≥ 60 years old at the time of screening (calculated from the date of birth to the date of screening) 2. ARI or exacerbation of cardiopulmonary diseases diagnosed at the time of admission. ARI or ARI-compatible symptoms were defined as either: * New onset or increase from baseline of: nasal congestion, rhinorrhea, sore throat, hoarseness, cough, sputum production, dyspnea, wheezing, hypoxemia, or * Admitting diagnosis suggestive of ARI (e.g., pneumonia, upper respiratory infection, bronchitis, influenza, cough, viral respiratory illness, respiratory distress, or respiratory failure), or * Admitting diagnosis was the exacerbation of an underlying cardiac or pulmonary disease involving acute respiratory symptoms within the previous 2 weeks (e.g., congestive heart failure \[CHF\], chronic obstructive pulmonary disease \[COPD\], or asthma exacerbation). 3. The participant agrees to

Related Trials